Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 9, 2017, Pages 1863-1873

  Nunes, Sara ^a   Madureira, Ana Raquel ^b   Campos, Débora ^b   Sarmento, Bruno ^c,d,e   Gomes, Ana Maria ^b   Pintado, Manuela ^b   Reis, Flávio ^a,f  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^e UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^f UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

bioavailability; nutraceutical potential; oral absorption; pharmacokinetics; phenolic compounds; Solid lipid nanoparticles

Indexed keywords

BIOCHEMISTRY; LIPOSOMES; NUTRITION; PHARMACOKINETICS; PHENOLS; PLANTS (BOTANY);

BIOAVAILABILITY; NUTRACEUTICALS; ORAL ABSORPTION; PHENOLIC COMPOUNDS; SOLID LIPID NANOPARTICLE (SLN);

NANOPARTICLES;

LIPID; NANOPARTICLE; PHENOL DERIVATIVE;

CHEMISTRY; DIETARY SUPPLEMENT; DRUG DELIVERY SYSTEM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; DIETARY SUPPLEMENTS; DRUG DELIVERY SYSTEMS; LIPIDS; NANOPARTICLES; PHENOLS;

EID: 85014884555     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2015.1031337     Document Type: Review

References (89)

1. Aaby, K., Hvattum, E., and Skrede, G., (2004). Analysis of flavonoids and other phenolic compounds using high-performance liquid chromatography with coulometric array detection:Relationship to antioxidant activity. J Agric. Food Chem. 52:4595–4603.
2. Anand, P., Kunnumakkara, A. B., Newman, R. A., and Aggarwal, B. B., (2007). Bioavailability of curcumin:Problems and promises. Mol. Pharm. 4:807–818.
3. Bargoni, A., Cavalli, R., Caputo, O., Fundar∫, A., Gasco, M. R., and Zara, G. P., (1998). Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm. Res. 15:745–750.
4. Berardini, N., Fezer, R., Conrad, J., Beifuss, U., Carle, R., and Schieber, A., (2005). Screening of mango (Mangifera indica L.) cultivars for their contents of flavonol O- and xanthone C-glycosides, anthocyanins, and pectin. J. Agric. Food Chem. 53:1563–1570.
5. Borgstrom, B., (1980). Importance of phospholipids, pancreatic phospholipase A2, and fatty acid for the digestion of dietary fat:In vitro experiments with the porcine enzymes. Gastroenterology. 78:954–962.
6. Bunjes, H., Westesen, K., and Koch, M. H. J., (1996). Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int. J. Pharm. 129:159–173.
7. Campos, D. A., Madureira, A. R., Gomes, A. M., Sarmento, B., and Pintado, M. M., (2014). Optimization of the production of solid Witepsol nanoparticles loaded with rosmarinic acid. Colloids Surf. B Biointerfaces. 115:109–117.
8. Chakraborty, S., Shukla, D., Mishra, B., and Singh, S., (2009). Lipid—an emerging platform for oral delivery of drugs with poor bioavailability. Eur. J. Pharm. Biopharm. 73:1–15.
9. Das, S., and Chaudhury, A., (2010). Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS Pharm. Sci. Tech. 12:62–76.
10. Desai, M. P., Labhasetwar, V., Amidon, G. L., and Levy, R. J., (1996). Gastrointestinal uptake of biodegradable microparticles:Effect of particle size. Pharm. Res. 13:1838–1845.
11. Dimitrios, B., (2006). Sources of natural phenolic antioxidants. Trends Food Sci. Technol. 17:505–512.
12. Dube, A., Nicolazzo, J. A., and Larson, I., (2010). Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate. Eur. J. Pharm. Sci. 41:219–225.
13. Dube, A., Nicolazzo, J. A., and Larson, I., (2011). Chitosan nanoparticles enhance the plasma exposure of (−)- epigallocatechin gallate in mice through an enhancement in intestinal stability. Eur. J. Pharm. Sci. 44:422–426.
14. Fang, J. Y., Hung, C. F., Hwang, T. L., and Huang, Y. L., (2005). Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations. J. Drug Targeting. 13:19–27.
15. Felice, F., Zambito, Y., Belardinelli, E., D'Onofrio, C., Fabiano, A., Balbarini, A., and Di Stefano, R., (2013). Delivery of natural polyphenols by polymeric nanoparticles improves the resistance of endothelial progenitor cells to oxidative stress. Eur. J. Pharm. Sci. 50:393–399.
16. Frozza, R. L., Bernardi, A., Paese, K., Hoppe, J. B., da Silva, T., Battastini, A. M., et al. (2010). Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J. Biomed. Nanotechnol. 6:694–703.
17. Gamboa, J. M., and Leong, K. W., (2013). In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv. Drug Deliv. Rev. 65:800–810.
18. Geetha, T., Kapila, M., Prakash, O., Deol, P. K., Kakkar, V., and Kaur, I. P., (2015). Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer. J. Drug Target. 23:159–169.
19. Ghosh, D., Choudhury, S. T., Ghosh, S., Mandal, A. K., Sarkar, S., Ghosh, A., et al. (2012). Nanocapsulated curcumin:Oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat. Chemico-Biological. Interactions. 195:206–214.
20. Han, S. B., Kwon, S. S., Jeong, Y. M., Yu, E. R., and Park, S. N., (2014). Physical characterization and in vitro skin permeation of solid lipid nanoparticles for transdermal delivery of quercetin. Int. J. Cosmet. Sci. 36:588–597.
21. Harde, H., Das, M., and Jain, S., (2011). Solid lipid nanoparticles:An oral bioavailability enhancer vehicle. Expert Opin. Drug Deliv. 8:1407–1424.
22. Hu, B., Ting, Y., Yang, X., Tang, W., Zeng, X., and Huang, Q., (2012). Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chito-san nanoparticles for enhancement of its bioavailability. Chem. Commun. 48:2421–2423
23. Huang, L., Weng, X., Chen, Z., Megharaj, M., and Naidu, R., (2014). Synthesis of iron-based nanoparticles using oolong tea extract for the degradation of malachite green. Spectrochim. Acta A Mol. Biomol. Spectrosc. 117:801–804.
24. Jani, P., Halbert, G. W., Langridge, J., and Florence, A. T., (1990). Nanoparticle uptake by the rat gastrointestinal mucosa-quantitation and particle-size dependency. J Pharm Pharmacol. 42:821–826.
25. Kähkönen, M. P., Hopia, A. I., Vuorela, H. J., Rauha, J. P., Pihlaja, K., Kujala, T. S., and Heinonen, M., (1999). Antioxidant activity of plant extracts containing phenolic compounds. J. Agric. Food Chem. 47:3954–3962.
26. Kakkar, V., Singh, S., Singla, D., and Kaur, I. P., (2011). Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res. 55:495–503.
27. Kaur, C., and Kapoor, H. C., (2001). Antioxidants in fruits and vegetables—the millennium's health. Int. J. Food Sci. Technol. 36:703–725.
28. Kaur, I. P., Kapila, M., and Agrawal, R., (2007). Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageing. Ageing Res Rev. 6:271–288.
29. Lai, F., Wissing, S. A., Müller, R. H., and Fadda, A. M., (2006). Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agricultural application:Preparation and characterization. AAPS Pharm. Sci. Tech. 7:E10–E18.
30. Lesschaeve, I., and Noble, A. C., (2005). Polyphenols:Factors influencing their sensory properties and their effects on food and beverage preferences. Am. J. Clin. Nutr. 81:330S–335S.
31. Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., and Lou, H., (2009). Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control Release. 133:238–244.
32. Liang, J., Li, F., Fang, Y., Yang, W., An, X., and Zhao, L., et al (2011). Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles. Colloids Surf. B Biointerfaces. 82:297–301.
33. Liu, A., Lou, H., Zhao, L., and Fan, P., (2006). Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J. Pharm. Biomed. Anal. 40:720–727.
34. Luo, C. F., Yuan, M., Chen, M. S., Liu, S. M., Zhu, L., Huang, B. Y., et al. (2011). Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int. J. Pharm. 410:138–144.
35. Lu, J. J., Cai, Y. J., and Ding, J., (2012). The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells. Mol. Cell Biochem. 360:253–260.
36. Lu, X., Ji, C., Xu, H., Li, X., Ding, H., Ye, M., et al. (2009). Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress. Int. J. Pharm. 375:89–96.
37. Lu, Q., Li, D. C., and Jiang, G. H., (2011). Preparation of a tea polyphenol nanoliposome system and its physicochemical properties. J. Agric. Food Chem. 59:13004–13011
38. Lukowski, G., and Werner, U., (1998). Investigation of surface and drug release of solid lipid nanoparticles loaded with acyclovir. Inter. Symp. Control. Rel. Bioact. Mater. 25:425–428.
39. Ma, Q. H., Kuang, Y. Z., Hao, X. Z., and Gu, N., (2009). Preparation and characterization of tea polyphenols and vitamin E loaded nanoscale complex liposome. J. Nanosci. Nanotechnol. 9:1379–1383.
40. Ma, D., Tremblay, P., Mahngar, K., Collins, J., Hudlicky, T., and Pandey, S., (2011). Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcumin. PLoS One. 6:e28780.
41. Maiti, K., Mukherjee, K., Gantait, A., Nazeer, A. H., Saha, B. P., and Mukherjee, P., (2005). Enhanced therapeutic benefit of quercetinphospholipid complex in carbon tetrachloride-induced acute liver injury in rats:A comparative study. Iran. J. Pharmac. Ther. 4:84–90.
42. Manach, C., Scalbert, A., Morand, C., Rémésy, C., and Jiménez, L., (2004). Polyphenols:Food sources and bioavailability. Am. J. Clin. Nutr. 79:727–747.
43. McVean, M., and Liebler, D. C., (1997). Inhibition of UVB induced DNA photodamage in mouse epidermis by topically applied alpha-tocopherol. Carcin. 18:1617–1622.
44. Montisci, M. J., Dembri, A., Giovannuci, G., Chacun, H., Duchêne, D., and Ponchel, G., (2001). Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats. Pharma Res. 18:829–837.
45. Müller, R. H., Mäder, K., and Gohla, S., (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm.50:161–177.
46. Müller, R. H., Radtke, M., and Wissing, S. A., (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54:S131–S155.
47. Munin, A., and Edwards-Lévy, F., (2011). Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics. 3:793–829.
48. Neves, A. R., Lúcio, M., Martins, S., Lima, J. L., and Reis, S., (2013). Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomedicine. 8:177–187.
49. Olbrich, C., and Müller, R. H., (1999). Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures. Int. J. Pharm. 180:31–39.
50. Pandita, D., Kumar, S., Poonia, N., and Lather, V., (2014). Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res. Intern. 62:1165–1174.
51. Parhi, R., and Suresh, P., (2010). Production of solid lipid nanoparticles-drug loading and release mechanism. J. Chem. Pharm. Res. 2:211–227.
52. Picone, P., Bondi, M. L., Montana, G., Bruno, A., Pitarresi, G., Giammona, G., and Di Carlo, M., (2009). Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers:Improved delivery by solid lipid nanoparticles. Free Radic. Res. 43:1133–1145.
53. Plianbangchang, P., Tungpradit, W., and Tiyaboonchai, W., (2007). Efficacy and safety of Curcuminoids loaded solid lipid nanoparticles facial cream as an anti-aging agent. Naresuan Univ. J. 15:73–78.
54. Ponchel, G., Montisci, M. J., Dembri, A., Durrer, C., and Duchêne, D., (1997). Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur. J. Pharm. Biopharm. 44:25–31.
55. Porrini, M., and Riso, P., (2008). Factors influencing the bioavailability of antioxidants in foods:A critical appraisal. Nutr. Metab. Cardiovasc Dis. 18:647–650.
56. Ramachandran, S., and Rajendra, P. N., (2011). Sesamol, a phenolic phytochemical present in Sesamum indicum, inhibits photocarcinogenesis by targeting UVB-induced lipid peroxidation and antioxidation depletion in Swiss albino mice. J. Res. Biochem. 1:001–008.
57. Ramalingam, P., and Ko, Y. T., (2015). Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles:Pharmacokinetic and brain distribution evaluation. Pharm. Res.32:389–402.
58. Reddy, N. J., Vali, D. N., Rani, M., and Rani, S. R., (2014). Evaluation of antioxidant, antibacterial and cytotoxic effects of green synthesized silver nanoparticles by Piper longum fruit. Mater. Sci. Eng. C Mater. Biol. Appl. 34:115–122.
59. Rein, M. J., Renouf, M., Cruz-Hernandez, C., Actis-Goretta, L., Thakkar, S. K., and da Silva, M. P., (2013). Bioavailability of bioactive food compounds:A challenging journey to bioefficacy. Br. J. Clin. Pharmacol. 75:588–602.
60. Ruckenstein, E., and Shulgin, I., (2005). Solubility of drugs in aqueous solutions:Part 5. Thermodynamic consistency test for the solubility data. Intern. J. Pharma. 292:87–94.
61. Ruktanonchai, U., Bejrapha, P., Sakulkhu, U., Opanasopit, P., Bunyapraphatsara, N., Junyaprasert, V., and Puttipipatkhachorn, S., (2009). Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. AAPS Pharm. Sci. Tech. 10:227–234.
62. Santos, I. S., Ponte, B. M., Boonme, P., Silva, A. M., and Souto, E. B., (2013). Nanoencapsulation of polyphenols for protective effect against colon–rectal cancer. Biotechnol. Adv. 31:514–523.
63. Scow, R. O., and Olivecrona, T., (1977). Effect of albumin on products formed from chylomicron triacylglycerol by lipoprotein lipase in vitro. Biochim. Biophys. Acta. 487:472–486.
64. Sessa, M., Balestrieri, M. L., Ferrari, G., Servillo, L., Castaldo, D., D'Onofrio, N., et al. (2014). Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems. Food Chem. 147:42–50.
65. Severino, P., Andreani, T., Macedo, A. S., Fangueiro, J. F., Santana, M. H., Silva, A. M., and Souto, E. B., (2011). Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J. Drug Deliv. 2012:1–10.
66. Shaikh, J., Ankola D. D., Beniwal, V., Singh, D., and Kumar, M. N., (2009). Nanoparticle encapsu-lation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37:223–230.
67. Srivastava, A. K., Bhatnagar, P., Singh, M., Mishra, S., Kumar, P., Shukla, Y., and Gupta, K. C., (2013). Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage. Int. J. Nanomedicine. 8:1451–1462
68. Shutava, T. G., Balkundi, S. S., Vangala, P., Steffan, J. J., Bigelow, R. L., Cardelli, J. A., et al. (2009). Layer-by-Layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano. 3:1877–1885.
69. Souto, E. B., Wissing, S. A., Barbosa, C. M., and Müller, R. H., (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 278:71–77.
70. Tabasco, R., Sánchez-Patán, F., Monagas, M., Bartolomé, B., Moreno-Arribas M. V., Peláez, C., and Requena, T., (2011). Effect of grape polyphenols on lactic acid bacteria and bifidobacteria growth:Resistance and metabolism. Food Microbiol. 28:1345–1352.
71. Tan, B. J., Liu, Y., Chang, K. L., Lim, B. K., and Chiu, G. N., (2012). Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. Int. J. Nanomedicine. 7:651–661.
72. Trombino, S., Cassano, R., Ferrarelli, T., Barone, E., Picci, E., and Mancuso, C., (2013). Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf. B Biointerfaces. 109:273–279.
73. Trombino, S., Cassano, R., Muzzalupo, R., Pingitore, A., Cione, E., and Picci, N., (2009). Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of β-carotene and α-tocopherol. Colloids Surf B Biointerfaces. 72:181–187.
74. Uner, M., (2006). Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC):Their benefits as colloidal drug carrier systems. Pharmazie. 61:375–386.
75. Vermerris, W., and Nicholson, R., (2008). Phenolic compound biochemistry. Springer. Dordrecht. The Netherlands.
76. Waghmare, A. S., Grampurohit, N. D., Gadhave, M. V., Gaikwad, D. D., and Jadhav, S. L., (2012). Solid lipid nanoparticles:A promising drug delivery system. Intern. Res. J. Pharm. 3:100–107.
77. Wang, M., Qin, L., Li, K., Zhu, R., Wang, W., and Wang, S., (2012b). The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles. AAPS Pharm Sci Tech. 13:1348–1354.
78. Wang, G., Wang, J. J., Yang, G. Y., Du, S. M., Zeng, N., Li, D. S., et al. (2012a). Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. Int. J. Nanomedicine. 7:271–280.
79. Wang, W., Zhu, R., Xie, Q., Li, A., Xiao, Y., Li, K., et al. (2012c). Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int. J. Nanomedicine. 7:3667–3677.
80. Weiss, J., Takhistov, P., and McClements, J., (2006). Functional materials in food nanotechnology. J. Food Sci. 71:107–116.
81. Westesen, K., Bunjes, H., Koch, M. H. J., (1997). Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release. 48:223–236.
82. Wissing, S. A., Müller, R. H., (2001). A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. Int. J. Cosmet. Sci. 23:233–243.
83. Wojdyło, A., Oszmiański, J., and Czemerys, R., (2007). Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 105:940–949.
84. Xie, X., Tao, Q., Zou, Y., Zhang, F., Guo, M., and Wang, Y., (2011). PLGA nanoparticles improve the oral bioavailability of curcumin in rats:Characterizations and mechanisms. J. Agric. Food Chem. 59:9280–9289.
85. Yallapu, M. M., Gupta, B. K., Jaggi, M., and Chauhan, S. C., (2010). Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid. Interface Sci. 351:19–29.
86. Yu, A., Wang, H., Wang, J., Cao, F., Gao, Y., Cui, J., and Zhai, G., (2011). Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion. J. Pharm. Sci. 100:933–941.
87. Yu, H., and Huang, Q., (2012). Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J. Agric. Food Chem. 60:5373–5379.
88. Zimmermann, E., and Müller, R. H., (2001). Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media. Eur. J. Pharm. Biopharm. 52:203–210.
89. zurMuhlen, Z., zurMuhlen, E., Niehus, H., and Mehnert, W., (1996) Atomic force microscopy studies of solid lipid nanoparticles. Pharm. Res. 13:1411–1416.